See more : CYBERDYNE Inc. (CYBQY) Income Statement Analysis – Financial Results
Complete financial analysis of Mauna Kea Technologies SA (MKEA.PA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mauna Kea Technologies SA, a leading company in the Medical – Devices industry within the Healthcare sector.
- Aluminum Corporation of China Limited (ACH) Income Statement Analysis – Financial Results
- All About, Inc. (2454.T) Income Statement Analysis – Financial Results
- ESGEN Acquisition Corporation (ESAC) Income Statement Analysis – Financial Results
- Banpu Public Company Limited (BPFG.F) Income Statement Analysis – Financial Results
- Berkshire Hathaway Inc. (BRYN.DE) Income Statement Analysis – Financial Results
Mauna Kea Technologies SA (MKEA.PA)
About Mauna Kea Technologies SA
Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.48M | 7.70M | 6.53M | 7.43M | 6.76M | 6.69M | 8.79M | 8.55M | 11.02M | 9.98M | 8.81M | 5.02M | 4.05M |
| Cost of Revenue | 2.01M | 1.99M | 2.15M | 2.26M | 2.12M | 2.20M | 2.72M | 2.53M | 3.68M | 3.04M | 2.71M | 1.58M | 1.41M |
| Gross Profit | 5.47M | 5.71M | 4.38M | 5.17M | 4.64M | 4.49M | 6.07M | 6.01M | 7.34M | 6.94M | 6.11M | 3.43M | 2.64M |
| Gross Profit Ratio | 73.19% | 74.17% | 67.09% | 69.59% | 68.68% | 67.12% | 69.05% | 70.35% | 66.64% | 69.51% | 69.30% | 68.42% | 65.26% |
| Research & Development | 4.07M | 3.31M | 3.23M | 3.16M | 3.00K | 21.00K | 4.45M | 4.65M | 4.58M | 3.61M | 3.26M | 2.30M | 1.83M |
| General & Administrative | 2.37M | 3.03M | 2.39M | 2.47M | 3.30M | 2.84M | 3.84M | 3.64M | 3.84M | 3.76M | 3.68M | 3.28M | 1.80M |
| Selling & Marketing | 1.49M | 2.21M | 2.03M | 2.48M | 2.87M | 2.61M | 8.37M | 11.67M | 12.75M | 11.17M | 12.53M | 6.29M | 4.36M |
| SG&A | 3.86M | 5.24M | 4.42M | 4.95M | 6.16M | 5.45M | 12.21M | 15.31M | 16.59M | 14.93M | 16.21M | 9.57M | 6.16M |
| Other Expenses | 6.53M | 8.54M | 8.69M | 10.09M | 10.47M | 0.00 | 0.00 | 232.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 14.46M | 17.08M | 16.34M | 18.20M | 16.64M | 14.20M | 16.06M | 18.74M | 21.16M | 18.46M | 19.07M | 11.56M | 6.63M |
| Cost & Expenses | 16.46M | 19.07M | 18.49M | 20.46M | 18.75M | 16.40M | 18.78M | 21.27M | 24.84M | 21.50M | 21.78M | 13.14M | 8.04M |
| Interest Income | 4.00K | 0.00 | 0.00 | -3.00K | 3.00K | 33.00K | 11.00K | 13.00K | 123.00K | 110.00K | 12.00K | 448.62K | 218.30K |
| Interest Expense | 254.00K | 28.00K | 49.00K | 603.00K | 481.00K | 418.00K | 0.00 | 11.00K | 25.00K | 100.00K | 0.00 | 253.23K | 116.57K |
| Depreciation & Amortization | -950.00K | 987.00K | 532.00K | -963.00K | 1.13M | 1.07M | 929.00K | 773.00K | 884.00K | 676.00K | 710.00K | 623.26K | 356.99K |
| EBITDA | -9.94M | -10.38M | -11.43M | -13.99M | -10.74M | -8.62M | -8.82M | -11.95M | -12.94M | -10.85M | -12.26M | -7.06M | -3.42M |
| EBITDA Ratio | -132.84% | -134.86% | -175.10% | -188.28% | -158.91% | -128.85% | -100.32% | -139.85% | -117.45% | -108.70% | -139.15% | -140.69% | -84.36% |
| Operating Income | -8.99M | -11.37M | -11.96M | -13.03M | -12.00M | -9.71M | -9.99M | -12.73M | -13.82M | -11.52M | -12.97M | -8.13M | -3.99M |
| Operating Income Ratio | -120.14% | -147.68% | -183.25% | -175.32% | -177.49% | -145.21% | -113.69% | -148.89% | -125.48% | -115.48% | -147.21% | -162.06% | -98.56% |
| Total Other Income/Expenses | -2.20M | -2.07M | -832.00K | -2.24M | -787.00K | -535.00K | 246.00K | 83.00K | -168.00K | 5.00K | -85.00K | 195.39K | 101.72K |
| Income Before Tax | -11.18M | -13.45M | -12.79M | -15.27M | -12.79M | -10.25M | -9.74M | -12.64M | -13.99M | -11.52M | -13.05M | -7.93M | -3.89M |
| Income Before Tax Ratio | -149.49% | -174.61% | -196.00% | -205.52% | -189.13% | -153.21% | -110.89% | -147.92% | -127.01% | -115.43% | -148.17% | -158.16% | -96.05% |
| Income Tax Expense | -4.00K | 875.00K | 49.00K | 103.00K | 432.00K | 20.00K | 246.00K | 0.00 | 1.00K | 0.00 | 1.00K | 1.50K | 2.95K |
| Net Income | -11.18M | -14.32M | -12.84M | -15.38M | -12.79M | -10.25M | -9.74M | -12.64M | -13.99M | -11.52M | -13.06M | -7.93M | -3.89M |
| Net Income Ratio | -149.43% | -185.97% | -196.75% | -206.90% | -189.13% | -153.21% | -110.89% | -147.92% | -127.01% | -115.43% | -148.20% | -158.19% | -96.12% |
| EPS | -0.21 | -0.32 | -0.36 | -0.52 | -0.47 | -0.49 | -0.55 | -0.84 | -1.01 | -0.84 | -0.97 | -0.71 | -0.11 |
| EPS Diluted | -0.21 | -0.32 | -0.36 | -0.52 | -0.47 | -0.42 | -0.47 | -0.75 | -0.90 | -0.75 | -0.87 | -0.67 | -0.09 |
| Weighted Avg Shares Out | 52.00M | 44.77M | 35.67M | 29.52M | 27.22M | 21.12M | 17.59M | 15.03M | 13.91M | 13.73M | 13.45M | 11.10M | 35.31M |
| Weighted Avg Shares Out (Dil) | 52.00M | 44.77M | 35.67M | 29.52M | 27.22M | 24.22M | 20.61M | 16.81M | 15.59M | 15.32M | 15.08M | 11.76M | 42.05M |
Source: https://incomestatements.info
Category: Stock Reports